Cocaine-induced alterations in neuro-development

Seminars in Speech and Language

Volumn 19, Issue 2, 1998, Pages 109-121

  Kosofsky, Barry E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Behavioral teratology; in utero cocaine; Prenatal drug exposure

Indexed keywords

COCAINE;

ARTICLE; BRAIN DISEASE; COCAINE DEPENDENCE; DEVELOPMENTAL DISORDER; FEMALE; HUMAN; MATERNAL BEHAVIOR; PREGNANCY; PRENATAL EXPOSURE; PSYCHOLOGICAL ASPECT;

BRAIN DISEASES; COCAINE-RELATED DISORDERS; CRACK COCAINE; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; MATERNAL BEHAVIOR; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 0031635554     PISSN: 07340478     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1064040     Document Type: Article

References (35)

1. Azuma, S. D., & Chasnoff, I. J. (1993). Outcome of children prenatally exposed to cocaine and other drugs: A path analysis of three-year data. Pediatrics, 92, 396-402.
2. Chasnoff, I. J., Griffith, D. R., Freier, C., & Murray, J. (1992). Cocaine/polydrug use in pregnancy: Two-year follow-up. Pediatrics, 89, 284-289.
3. Chasnoff, I. J., Griffith, D. R., MacGregor, S., Dirkes, K., & Burns, K. A. (1989). Temporal patterns of cocaine use in pregnancy. JAMA, 261, 1741-1744.
4. Chiriboga, C. A., Bateman, D. A., Brust, J. C. M., & Hauser, W. A. (1993). Neurologic findings in neonates with intrauterine cocaine exposure. Pediatric Neurology, 9, 115-119.
5. Chiriboga, C. A., Vibbert, M., Malouf, R., Suarez, M. S., Abrams, E. J., Heagarty, M. C., Brust, J. C. M., & Hauser, W. A. (1995). Neurological correlates of fetal cocaine exposure: Transient hypei tonia of infancy and early childhood. Pediatrics, 96, 1070-1077.
6. Delaney-Black, V., Covington, C., Ostrea, E., Jr., Romero, A., Baker, D., Tagle, M.- T., Nordstrom-Klee, B., Silvestre, M. A., Angelilli, M. L., Hack, C., & Long, J. (1996). Prenatal cocaine and neonatal outcome: Evaluation of dose-response relationship. Pediatrics, 98, 735-740.
7. Dixon, S. D., & Bejar, R. (1989). Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. Journal of Pediatrics, 115, 770-778.
8. Doberczak, T. M., Shanzer, S., Senie, R. T., & Kandall, S. R. (1988). Neonatal neurologic and electroencephalographic effects of intrauterine cocaine exposure. Journal of Pediatrics, 113(2), 354-358.
9. Gold, M. S., Washton, A. M. & Dackis, C. A. (1985). Cocaine abuse: Neurochemistry, phenomenology, and treatment. In N.J. Kozel & E.H. Adams (Eds.). Cocaine use in America: epidemiologic and clinical perspectives, 61st ed. (pp. 130-150). Washington, DC: NIDA Research Monograph No. 61.
10. Grimm, V. E. (1987). Effect of teratogenic exposure on the developing brain: Research strategies and possible mechanisms. Developmental Pharmacology and Therapeutics, 10, 328-345.
11. Hoyme, H. E., Jones, K. L., Dixon, S. D., Jewett, T., Hanson, J. W., Robinson, L. K., Msall, M. E., & Allanson, J. E. (1990). Prenatal cocaine exposure and fetal vascular disruption. Pediatrics, 85, 743-747.
12. Jacobson, S. W., Jacobson, J. L., Sokol, R. J., Martier, S. S., & Chiodo, L. M. (1996). New evidence for neurobehavioral effects of in utero cocaine exposure. The Journal of Pediatrics, 129, 581-589.
13. Konkol, R. J., Murphey, L. J., Ferriero, D. M., Dempsey, D. A., & Olsen, G. D. (1994). Cocaine metabolites in the neonate: Potential for toxicity. Journal of Child Neurology, 9, 242-248.
14. Kramer, L. D., Locke, G. E., Ogunyemi, A., & Nelson, L. (1990). Neonatal cocaine-related seizures. Journal of Child Neurology, 5(1), 60-64.
15. Lester, B. M., Corwin, M. J., Sepkoski, C., Seifer, R., Peucker, M., McLaughlin, S., & Golub, H. L. (1991). Neurobehavioral syndromes in cocaine-exposed newborn infants. Child Development, 62, 694-705.
16. Lester, B. M., LaGasse, L., Freier, K., & Bninner, S. (1996). Studies of cocaine-exposed human infants. In C. L. Wetherington, V. L. Smeriglio, & L. P. Finnegan (eds.). Behavioral Studies of Drug-Exposed Offspring: Methodological Issues in Human and Animal Research (pp. 164-210). Washington, D.C.: U.S. Government Printing Office.
17. Little, B. B., & Snell, L. M. (1991). Brain growth among fetuses exposed to cocaine in utero: Asymmetrical growth retardation. Obstetrics and Gynecology, 77, 361-364.
18. Locke, J. L. (1992a). Neural specializations for language: A developmental perspective. Seminars in Neuroscience, 4, 425-431.
19. Locke, J. L. (1992b). The biology of spoken language: Thirty years of research on developmental neurolinguistics. Pediatric Neurology, 8, 245-250.
20. Mayes, L. C., Bornstein, M. H., Chawarska, K., & Granger, R. H. (1995). Information processing and developmental assessments in 3-month-old infants exposed prenatally to cocaine. Pediatrics, 95, 539-545.
21. Mayes, L. C., Granger, R. H., Bornstein, M. H., & Zuckerman, B. (1992). The problem of prenatal cocaine exposure: A rush to judgement. Journal of the American Medical Association, 267, 406-408.
22. Mayes, L. C., Granger, R. H., Frank, M. A., Schottenfeld, R., & Bornstein, M. H. (1993). Neurobehavioral profiles of neonates exposed to cocaine prenatally. Pediatrics, 91, 778-783.
23. Mentis, M., & Lundgren, K. (1995). Effects of prenatal exposure to cocaine and associated risk factors on language development. Journal of Speech and Hearing Research, 38, 1303-1318.
24. Mirochnick, M., Frank, D. A., Cabrai, H., Turner, A., & Zuckerman, B. (1995). Relation between meconium concentration of the cocaine metabolite benzoylecgonine and fetal growth. The Journal of Pediatrics, 126, 636-638.
25. Napiorkowski, B. S., Lester, B. M., Freier, M. C., Brunner, S., Dietz, L., Nadra, A., & Oh, W. (1996). Effects of in utero substance exposure on infant neurobehavior. Pediatrics, 98, 71-75.
26. National Institutes of Health, Department of Health and Human Services. (1995). National pregnancy and health survey. A national institute on drug abuse report. Washington, DC: U.S. Government Printing Office.
27. Nulman, I., Rovet, J., Altmann, D., Bradley, C., Einarson, T., & Koren, G. (1994). Neurodevelopment of adopted children exposed in utero to cocaine. Canadian Medical Association Journal, 151, 1592-1597.
28. Richardson, G. A., Conroy, M. L., & Day, N. L. (1997). Prenatal cocaine exposure: Effects on the development of school-age children. Neurotoxicology and Teratology, 18, 627-634.
29. Ritchie, J. M. & Greene, N. M. (1985). Cocaine. In A. G. Gilman, L. S. Goodman, T. W. Rail, & F. Murad (Eds.), The pharmacologic basis of therapeutics, 7th ed. (pp. 309-310). New York: Macmillan.
30. Shih, L., Cone-Wesson, B., & Reddix, B. (1988). Effects of maternal cocaine abuse on the neonatal auditory system. International Journal of Pediatric Otorhinolaryngology, 15, 245-251.
31. Tronick, E. Z., Frank, D. A., Cabral, H., Mirochnick, M., & Zuckerman, B. (1996). Late dose-response effects of prenatal cocaine exposure on newborn behavioral performance. Pediatrics, 98, 76-83.
32. Wilkins, A. S., Marota, J. A., Tabit, E., & Kosofsky, B. E. (1998). Transplacental cocaine exposure 3: mechanisms underlying altered brain development. Neurotoxicology and Teratology, 20(3).
33. Woods, J. R., Plessinger, M. A., & Clark, K. E. (1987). Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA, 257, 957-961.
34. Zuckerman, B., & Bresnahan, K. (1991). Developmental and behavioral consequences of prenatal drug and alcohol exposure. Pediatric Clinics of North America, 38, 1387-1406.
35. Zuckerman, B., Frank, D. A., Hingson, R., Amaro, H., Levenson, S. M., & Kayne, H. (1989). Effects of maternal marijuana and cocaine use on fetal growth. New England Journal of Medicine, 12, 762-768.